Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erhuang Decoction vs GeneTime Cream for radiation-induced skin injury
ChiCTR2000040705Phase 3Recruiting
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Dec 2020
- Countries
- 1
01
Overview
Phase 3, randomised trial of erhuang decoction in radiodermatitis (2 arms), sponsored by China Academy of Chinese Medical Sciences. Primary endpoint: Skin lesion remission rate. Started Dec 2020; status: recruiting.
02
Drugs
erhuang decoction
03
Conditions
radiodermatitis
Beyond the preview
Go deeper on ChiCTR2000040705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040705.